Evaluation of urea as a normalization factor for nasosorption samples

V. Steffen (South San Francisco, United States of America), F. Cai (South San Francisco, United States of America), T. Staton (South San Francisco, United States of America), M. Bremer (South San Francisco, United States of America), P. Banerjee (South San Francisco, United States of America), R. Bauer (South San Francisco, United States of America)

Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session: Asthma: outcomes of clinical trials and cohorts
Session type: Thematic Poster
Number: 4256
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Steffen (South San Francisco, United States of America), F. Cai (South San Francisco, United States of America), T. Staton (South San Francisco, United States of America), M. Bremer (South San Francisco, United States of America), P. Banerjee (South San Francisco, United States of America), R. Bauer (South San Francisco, United States of America). Evaluation of urea as a normalization factor for nasosorption samples. 4256

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of the standard deviation of haematocrit as a measure of homogeneity of the sample in blood gas syringes
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001

Determination of blood leukocyte concentration with constant time acquisition volume is comparable with individualized analysis with beads as internal reference standard
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008

Rapid DNA extraction from dried blood spots for the alpha-1 antitrypsin deficiency detection by real-time PCR
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012


Blood lactate level in patients with severe COVID-19: Does it have any added value?
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in serum and bronchoalveolar lavage fluid of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004

High levels of serum cholesterol – protective and predictive factor for activation of tuberculosis; practical considerations
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009

Long-term effect of hepatocyte growth factor in the normal lung: A stereological assessment
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011

Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Matrix metalloproteinase-9 (MMP-9) and transforming growth factor β1 (TGF β1) levels in induced sputum and serum samples of mild and severe asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001

Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre
Source: International Congress 2017 – Rare diseases
Year: 2017


Plasma protein profiling in alpha-1-antitrypsin deficiency
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Plasma stromal derived factor 1 alpha levels in pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 141s
Year: 2006

Accurate and reliable determination of alpha1-antitrypsin levels in respiratory patients using dried blood spot specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Glomerular filtration rate is a confounder for determination of serum soluble mesothelin
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019

Comparison of physical and biochemical variables of EBC samples
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

Genomic DNA extraction from small amounts of serum to be used for α1-antitrypsin genotype analysis.
Source: Eur Respir J 2003; 21: 911
Year: 2003


Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Identification of MDA associated clusters in exhaled breath samples of patient measurements from GC-IMS spectra
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

The prognostic value of increased blood urea nitrogen in pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010